Logo image of HLGN

HELIOGEN INC (HLGN) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:HLGN - US42329E2046 - Common Stock

2.45 USD
+0.1 (+4.26%)
Last: 11/7/2023, 8:04:01 PM
Fundamental Rating

3

HLGN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 91 industry peers in the Electrical Equipment industry. HLGN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HLGN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year HLGN has reported negative net income.
HLGN had a negative operating cash flow in the past year.
HLGN Yearly Net Income VS EBIT VS OCF VS FCFHLGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -50M -100M

1.2 Ratios

With a Return On Assets value of -61.75%, HLGN is not doing good in the industry: 88.51% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -107.61%, HLGN is doing worse than 77.01% of the companies in the same industry.
Industry RankSector Rank
ROA -61.75%
ROE -107.61%
ROIC N/A
ROA(3y)-55.04%
ROA(5y)N/A
ROE(3y)-72.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HLGN Yearly ROA, ROE, ROICHLGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -20 -40 -60 -80 -100

1.3 Margins

The Gross Margin of HLGN (6.98%) is worse than 67.82% of its industry peers.
HLGN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HLGN Yearly Profit, Operating, Gross MarginsHLGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 -1K -2K -3K

6

2. Health

2.1 Basic Checks

HLGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HLGN has been increased compared to 1 year ago.
There is no outstanding debt for HLGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HLGN Yearly Shares OutstandingHLGN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 50M 100M 150M
HLGN Yearly Total Debt VS Total AssetsHLGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -4.33, we must say that HLGN is in the distress zone and has some risk of bankruptcy.
HLGN's Altman-Z score of -4.33 is on the low side compared to the rest of the industry. HLGN is outperformed by 86.21% of its industry peers.
There is no outstanding debt for HLGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.33
ROIC/WACCN/A
WACC11.31%
HLGN Yearly LT Debt VS Equity VS FCFHLGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 50M -50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 2.43 indicates that HLGN has no problem at all paying its short term obligations.
HLGN has a Current ratio of 2.43. This is comparable to the rest of the industry: HLGN outperforms 57.47% of its industry peers.
A Quick Ratio of 2.35 indicates that HLGN has no problem at all paying its short term obligations.
The Quick ratio of HLGN (2.35) is better than 77.01% of its industry peers.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 2.35
HLGN Yearly Current Assets VS Current LiabilitesHLGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 50M 100M 150M 200M

3

3. Growth

3.1 Past

HLGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1330.78%.
HLGN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.62%.
EPS 1Y (TTM)-1330.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)-16.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-41.72%

3.2 Future

Based on estimates for the next years, HLGN will show a very strong growth in Earnings Per Share. The EPS will grow by 36.39% on average per year.
The Revenue is expected to grow by 163.58% on average over the next years. This is a very strong growth
EPS Next Y13.38%
EPS Next 2Y-0.44%
EPS Next 3Y26.69%
EPS Next 5Y36.39%
Revenue Next Year114.44%
Revenue Next 2Y219.55%
Revenue Next 3Y254.29%
Revenue Next 5Y163.58%

3.3 Evolution

HLGN Yearly Revenue VS EstimatesHLGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
HLGN Yearly EPS VS EstimatesHLGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 20 -20 40

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HLGN. In the last year negative earnings were reported.
Also next year HLGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HLGN Price Earnings VS Forward Price EarningsHLGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HLGN Per share dataHLGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

HLGN's earnings are expected to grow with 26.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.44%
EPS Next 3Y26.69%

0

5. Dividend

5.1 Amount

HLGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HELIOGEN INC

NYSE:HLGN (11/7/2023, 8:04:01 PM)

2.45

+0.1 (+4.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-13 2023-11-13/amc
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner Change-43.86%
Ins Owners122.28%
Ins Owner Change0%
Market Cap14.41M
Revenue(TTM)11.15M
Net Income(TTM)-95.04M
Analysts77.78
Price Target16.07 (555.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.29%
Min EPS beat(2)-9.75%
Max EPS beat(2)42.33%
EPS beat(4)2
Avg EPS beat(4)9.36%
Min EPS beat(4)-24.02%
Max EPS beat(4)42.33%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-67.81%
Min Revenue beat(2)-69.29%
Max Revenue beat(2)-66.34%
Revenue beat(4)1
Avg Revenue beat(4)-41.93%
Min Revenue beat(4)-69.29%
Max Revenue beat(4)16.14%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3400%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4244.17%
EPS NY rev (1m)0%
EPS NY rev (3m)-4088.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-40.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.29
P/FCF N/A
P/OCF N/A
P/B 0.16
P/tB 0.16
EV/EBITDA N/A
EPS(TTM)-15.4
EYN/A
EPS(NY)-15.89
Fwd EYN/A
FCF(TTM)-14.16
FCFYN/A
OCF(TTM)-13.07
OCFYN/A
SpS1.9
BVpS15.02
TBVpS15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -61.75%
ROE -107.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.98%
FCFM N/A
ROA(3y)-55.04%
ROA(5y)N/A
ROE(3y)-72.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 275.2%
Cap/Sales 57.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.43
Quick Ratio 2.35
Altman-Z -4.33
F-Score5
WACC11.31%
ROIC/WACCN/A
Cap/Depr(3y)414.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)85.51%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1330.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
EPS Next Y13.38%
EPS Next 2Y-0.44%
EPS Next 3Y26.69%
EPS Next 5Y36.39%
Revenue 1Y (TTM)-16.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-41.72%
Revenue Next Year114.44%
Revenue Next 2Y219.55%
Revenue Next 3Y254.29%
Revenue Next 5Y163.58%
EBIT growth 1Y-1.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.92%
EBIT Next 3Y32.86%
EBIT Next 5Y38.15%
FCF growth 1Y-126.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-124.88%
OCF growth 3YN/A
OCF growth 5YN/A

HELIOGEN INC / HLGN FAQ

Can you provide the ChartMill fundamental rating for HELIOGEN INC?

ChartMill assigns a fundamental rating of 3 / 10 to HLGN.


What is the valuation status of HELIOGEN INC (HLGN) stock?

ChartMill assigns a valuation rating of 1 / 10 to HELIOGEN INC (HLGN). This can be considered as Overvalued.


Can you provide the profitability details for HELIOGEN INC?

HELIOGEN INC (HLGN) has a profitability rating of 0 / 10.


Can you provide the financial health for HLGN stock?

The financial health rating of HELIOGEN INC (HLGN) is 6 / 10.